Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol and prostate cancer.

Michael R Freeman1, Keith R Solomon

  • 1The Urological Diseases Research Center, Children's Hospital Boston, Boston, Massachusetts 02115, USA. michael.freeman@tch.harvard.edu

Journal of Cellular Biochemistry
|December 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies.

Biomarker research·2026
Same author

DNA Binding by BosR Controls RpoS-Dependent and -Independent Gene Expression in Borrelia burgdorferi.

Molecular microbiology·2025
Same author

ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignancies.

Endocrine-related cancer·2025
Same author

Comparison of QuPath and HALO Platforms for Analysis of the Tumor Microenvironment in Prostate Cancer.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Molecular medicine (Cambridge, Mass.)·2025
Same author

Extracellular vesicle heterogeneity through the lens of multiomics.

Cell reports. Medicine·2025

Cholesterol accumulation in prostate cancer cells, particularly in lipid rafts, promotes disease progression. Understanding this link may reveal new biomarkers and therapeutic targets for aggressive prostate cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Cholesterol is a neutral lipid crucial for cell membrane structure and function.
  • Lipid rafts, cholesterol-rich membrane domains, act as platforms for signal transduction.
  • Cholesterol homeostasis is disrupted in prostate cancer (PCa), with accumulation observed in tumors.

Purpose of the Study:

  • To review the established links between cholesterol and prostate cancer.
  • To focus on how cholesterol accumulation in lipid rafts promotes PCa progression.
  • To explore the potential of targeting cholesterol metabolism for PCa therapy.

Main Methods:

  • Literature review of studies on cholesterol, lipid rafts, and prostate cancer.
  • Analysis of proposed mechanisms for cholesterol-induced signaling pathway activation.

Related Experiment Videos

  • Discussion of potential therapeutic strategies targeting cholesterol.

    • Main Results:

    • Cholesterol accumulation in PCa cells, especially in lipid rafts, may enhance oncogenic signaling.
    • Increased cholesterol can lead to raft coalescence, sequestering pro-cancer signaling molecules.
    • Disrupted cholesterol homeostasis is linked to PCa progression and hormone-refractory disease.

    Conclusions:

    • Cholesterol's role in lipid raft organization is critical for prostate cancer progression.
    • Targeting cholesterol metabolism or lipid raft function may offer novel therapeutic avenues for PCa.
    • Further research into cholesterol-rich domain proteins could identify new biomarkers and drug targets.